piMed Consulting was founded in 2018 and has supported multiple startup companies to successfully reach important business milestones exemplified by asset sales to global pharma companies and achieving ROI.

Eva earned her PhD in Immunology at Karolinska Institute, Sweden and holds an MBA from Heriot-Watt University, Scotland.

As the CEO, she transitioned a diagnostic start up to acquisition by Cepheid now a part of Danaher. At Roche Diagnostics International she worked in US and Switzerland in R&D and business functions.

In 2020, Eva joined piMed Consulting AG and supports biotech companies with biomarker development and startup diagnostic companies with technology and commercial expertise.

She is a board member of, public and private, life science and biotechnology companies.

Pavel has an extensive Translational Medicine experience gained at world leading academic medical Institutions and working at Roche Pharmaceuticals in Switzerland.

His scientific expertise in tumor immunology and cancer immunotherapy is documented in 120 peer reviewed and highly cited publications.

Pavel has held positions as professor and clinical head of oncology, hematology and internal medicine at the Karolinska Institute, Sweden.

During his time at Roche Pavel was at leading positions and a key contributor to multiple successful clinical development programs in cancer immunotherapy. His work generated multiple patents and awards, e.g. “The Drug Discovery of the Year Award 2015” by the British Pharmacological Society.

Eva Pisa Ph.D. MBA

Co-owner

Leader in health diagnostics and biotechnology

Pavel Pisa M.D. Ph.D.

Founder

Medical expert in all stages of drug development in oncology

Who we are